Serum markers of brain damage and outcome prediction in patients after severe head injury

Br J Neurosurg. 1999 Feb;13(1):56-9. doi: 10.1080/02688699944195.

Abstract

The objective of the study was to investigate the validity of outcome prediction after severe head injury using serum levels of S-100B protein and neuron specific enolase. Eighty-two patients with severe head injury were included in this prospective study. Venous blood samples were taken after admission and every 24 h for a maximum of 10 consecutive days. For values of S-100 from 0 to 2.5 micrograms/l, and for values of NSE from 0 to 100 micrograms/l the sensitivity and specificity of incremental values as a predictor of unfavourable outcome were calculated and Receiver Operator Characteristics curves were plotted. Serum S-100 protein was found to be clearly superior to neuron specific enolase in terms of predicting outcome with higher specificity, sensitivity, positive and negative predictive value. According to our experience, S-100B protein represents the most promising serum marker of brain cell damage currently under investigation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Brain Damage, Chronic / blood
  • Brain Damage, Chronic / diagnosis*
  • Craniocerebral Trauma / blood
  • Craniocerebral Trauma / diagnosis*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phosphopyruvate Hydratase / blood
  • Prospective Studies
  • S100 Proteins / blood
  • Sensitivity and Specificity

Substances

  • Biomarkers
  • S100 Proteins
  • Phosphopyruvate Hydratase